Milestone Scientific Profit Margin

The latest profit margin for MLSS is -58.68% as of June 2026. That compares with -101.8% in the prior-year period — up 42.4% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Milestone Scientific's historical trend and sector peers before judging valuation or financial health.

Over the past year, MLSS's profit margin moved from -101.8% to -58.68% — a 42.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Milestone Scientific's valuation or profitability profile.

Against Healthcare companies, MLSS currently prints -58.68% for profit margin, while the sector average sits near 10.58%. That is roughly 654.6% below the sector mean. Large gaps often invite a closer look at Milestone Scientific's growth, margins, and balance sheet.

Profit Margin shows how effectively Milestone Scientific converts resources into returns. At -58.68%, MLSS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -101.8% in the prior-year period — up 42.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MLSS's profit margin (-58.68%), review year-over-year change from -101.8%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.